Get started
Author

Marián Oltman

Observed names: M Oltman, M. Oltman, Marian OLTMAN, Marian Oltman
OpenAlex ID: A5000333738
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
2016 · Sarah Blach, Stefan Zeuzem, et al. · ˜The œLancet. Gastroenterology & hepatology · 2,007
PDF
The present and future disease burden of hepatitis C virus ( HCV ) infections with today's treatment paradigm – volume 2
2015 · A. Hatzakis, V. Chulanov, et al. · Journal of Viral Hepatitis · 125
PDF
Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 2
2015 · V. Saraswat, S. Norris, et al. · Journal of Viral Hepatitis · 92
PDF
Pulmonary complications in patients with inflammatory bowel disease.
1999 · L Kuzela, A Vavrecka, et al. · PubMed · 75
Strategies to manage hepatitis C virus ( HCV ) infection disease burden – volume 2
2015 · E. Gane, D. Kershenobich, et al. · Journal of Viral Hepatitis · 54
PDF
Prospective follow-up of patients with bile duct strictures secondary to laparoscopic cholecystectomy, treated endoscopically with multiple stents.
2005 · Ladislav Kuzela, Marian Oltman, et al. · PubMed · 44
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
2018 · Sylvia Drazilova, Martin Janicko, et al. · Canadian Journal of Gastroenterology and Hepatology · 26
PDF
Links between prolonged exposure to xenobiotics, increased incidence of hepatopathies, immunological disturbances and exacerbation of latent epstein-barr virus infections
1995 · D. Stanček, G. Košecká, et al. · International Journal of Immunopharmacology · 12
Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
2001 · D Stancek, N Fuchsberger, et al. · PubMed · 9
New therapeutic options for HCV in Central Europe
2016 · Robert Flisiak, Petr Urbánek, et al. · Clinical and Experimental Hepatology · 7
PDF
Epidemiology of Helicobacter Pylori Infection in the Slovak Republic
2011 · Ladislav Kuzela, Marian Oltman, et al. · Hepatogastroenterology · 6
Inequalities in cancer deaths by age, gender and education
2017 · Marek Gróf, Tatiana Vagašová, et al. · Central European Journal of Public Health · 4
PDF
Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin
2011 · Petr Husa, Marian Oltman, et al. · European Journal of Gastroenterology & Hepatology · 3
Therapy-induced antibodies to interferon-alpha 2a recognise its receptor-binding site.
1998 · H Liptáková, E Kontseková, et al. · PubMed · 3
[Percutaneous biopsy of the liver].
2003 · L Skladaný, P Jarcuska, et al. · PubMed · 2
Questionnaire for risk factors of alcoholic and nonalcoholic fatty liver disease
2022 · Maria SZANTOVA, Lubomir SKLADANY, et al. · Bratislavské lekárske listy/Bratislava medical journal · 1
PDF
Prospective Evaluation of Mucosal Changes in the Small Bowel by Capsule Endoscopy in Patients with Crohn’s Disease Treated with Infliximab and Adalimumab
2012 · L Kuzela, Marián Oltman, et al. · Journal of Gastroenterology and Hepatology Research · 1
[Endoscopic therapy of pancreatic pseudocysts].
2000 · A Vavrecka, L Kuzela, et al. · PubMed · 1
THU-103 Results froma phase 2a trial with the CD80 antagonist RhuDex as a second line treatment for primary biliary cholangitis
2024 · Gideon Hirschfield, Vaclav Hejda, et al. · Journal of Hepatology
Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics
2020 · Lubomír Skladaný, Marian Oltman, et al. · International Journal of Public Health
2972 Treatment of Chronic Hepatitis C With SOF/LDV Leads to a Significant Decrease of Fasting Glycaemia in Cirrhotic and IFG/T2DM Patients but Treatment With 3D Combo Only in IFG/T2DM Patients
2019 · Sylvia Drazilova, Martin Janicko, et al. · The American Journal of Gastroenterology
Pľúcne komplikácie u pacientov s nešpecifickými črevnými zápalmi : Český a slovenský gastroenterologický kongres, Brno, 9.-11.9.1999. Abstrakta
2015 · Ladislav Kužela, Branislav. Drugda, et al. · Gastroenterologie a hepatologie
Efficacy and safety of peginterferon α-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe
2011 · Petr Urbanek, Marian Oltman, et al. · European Journal of Gastroenterology & Hepatology
Efficacy and safety of peginterferon alpha-2a (40 kD) plusribavirin in treatment-naive chronic hepatitis C patients inCentral and Eastern Europe
2011 · Petr Urbánek, Marián Oltman, et al. · European Journal of Gastroenterology & Hepatology
The efficacy of peginterferon alfa-2a (40 kD) in a largeopen-label expanded access programme in Eastern Europe
2009 · Petr Urbánek, Marián Oltman, et al.
Works count: 30
Citation count: 2,472
H-index: 9
I10-index: 8
Year
Topic
Type